Amarin Corp Plc (AMRN)

[couldbebetter]

deut8-18, You may be aware of AMRN's failed trial on Huntington's,
However, it was "trending" toward effectiveness. The company used
what we would say is a very low doseage for that trial. Perhaps at a
substantially higher dose Vascepa would have more of an impact on
the disease. If I knew of anyone who was at risk for this disease
I would encourage them to get on 4 grams of Vascepa per day...and
up to 6 grams if they had the disorder. (At least until or unless
something proven comes along.) A high school friend of mine died at
far too young an age from this...I hope a cure is found.